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Abstract 
Background: Metastasis underlies most colorectal cancer mortality. Cancer cells spread 
through the body as single cells or small clusters of cells that have an invasive, mesenchymal, 
non-proliferative phenotype. At the secondary site, they revert to a proliferative ‘tumor 
constructing’ epithelial phenotype to rebuild a tumor. We previously developed a unique in 
vitro 3D model, called LIM1863-Mph, which faithfully recapitulates these reversible 
transitions that underpin colorectal cancer metastasis. Wnt signaling plays a key role in these 
transitions and is initiated by the coupling of extracellular Wnt to Frizzled (FZD). Using the 
LIM1863-Mph model system we demonstrated that the Wnt receptor FZD7 is necessary for 
mesenchymal to epithelial transition (MET). Here we investigate the role of Wnt ligands in 
MET. Results: Wnt secretion is dependent on palmitoylation by the enzyme Porcupine 
(PORC). A PORC inhibitor (IWP2) that prevents the secretion of Wnt proteins including 
Wnt2B, blocked the epithelial transition of mesenchymal LIM1863-Mph cells. Wnt gene array 
analysis identified several Wnts that are upregulated in epithelial compared to mesenchymal 
LIM1863-Mph cells, suggesting these ligands in MET. Wnt2B was the most abundant 
differentially expressed Wnt gene. Indeed, recombinant Wnt2B could overcome the IWP2-
mediated block in epithelial transition of mesenchymal LIM1963-Mph cells. 
Conclusion: Wnt2B co-operates with Frizzled7 to mediate MET in colorectal cancer.  
 
 
 
  
Introduction 
Colorectal cancer (CRC) is a major health problem worldwide and, similar to other forms 
of cancer, it is much harder to treat once it has spread to other organs in the body. A necessary 
step in the genesis of most CRCs is deregulation of the β-catenin dependent Wnt signaling 
pathway (Clevers and Nusse 2012), which occurs through genetic mutation of downstream 
pathway components, primarily the tumor suppressor gene Adenomatous Polyposis Coli (APC) 
(Fearon 2011). At a molecular level, the Wnt/β-catenin pathway regulates the cytoplasmic and 
nuclear levels of β-catenin via a cytoplasmic destruction complex that includes APC, Axin and 
GSK3β. Mutations of APC in CRC disrupts this regulation and β-catenin accumulates in the 
cytoplasm, translocates to the nucleus and leads to the constitutive activation of TCF/LEF/β-
catenin transcription of target genes (Korinek et al. 1997, van de Wetering et al. 2002). 
However, the level of nuclear β-catenin is variable in CRC despite activating mutations in the 
downstream components of the pathway (Brabletz et al. 1998, Brabletz et al. 2001), indicating 
additional regulation of the Wnt/β-catenin pathway by the tumor environment (Vincan and 
Barker 2008). 
 
The majority of CRCs are well differentiated forming organized tubular structures, yet they 
still metastasize, and therefore differentiation status is often a poor prognostic factor for this 
cancer. Both primary and secondary (metastases) well-differentiated tumors have clearly 
defined localized invasive areas where the tubular structures of the CRC is reorganized yielding 
tumor cell sheets and isolated tumor cells interspersed with the stroma (Brabletz et al. 1998, 
Brabletz et al. 2001). Histological detection of invasive areas in the tumor predicts poor 
outcome, independent of tumor staging (Ueno et al. 2014, Wong et al. 2003). Tumor cells 
engaged in tubular structures are well differentiated with membrane β-catenin (polarized 
epithelial cells) that stain with Ki-67. In contrast, cell division (Ki-67 staining) is decreased or 
undetected in de-differentiated (migratory, invasive, mesenchymal) tumor cells with intense 
cytoplasmic and nuclear β-catenin at invasive areas (Brabletz et al. 2001). Based on these 
phenotypic changes, de-differentiation at the invasive front is referred to as an epithelial to 
mesenchymal transition (EMT) (Kirchner and Brabletz 2000). Once in the secondary organs, 
the reverse transition occurs (MET) which re-instates the epithelial, proliferative phenotype. 
Notably, the pathology of primary and secondary tumors for most CRCs is the same (Brabletz 
et al. 2005a, Thiery 2002). Transitions between epithelial and mesenchymal states are thus 
dynamic and reversible. Presumably, this reversal of de-differentiated disseminated cells to an 
epithelial phenotype is necessary to re-instate cell division so that the tumor structure can be 
re-built at the secondary site (Thiery 2002, Vincan 2004).  
During metastasis cancer cells disseminate through the body as single cells or small clusters 
of cells and can remain ‘dormant’ for many years (MacDonald et al. 2002, Naumov et al. 2002). 
Moreover, disseminated cancer cells (mesenchymal, non-proliferating) evade conventional 
anti-cancer therapies, which in general target proliferating cells. The ability to eliminate these 
‘dormant’ cancer cells is critical for curative treatment. Initiation of tumor growth at the 
secondary site is the rate-limiting step in metastasis (Chambers et al. 2002). Consequently, 
circumventing release from dormancy offers a further avenue for therapeutic intervention. 
However, the molecular mechanisms controlling early events of release from ‘dormancy’ are 
still largely unknown due to the complexity this presents for analysis in vivo. To overcome this 
limitation, we have established a unique in vitro morphogenesis culture system using the 
human colorectal cancer cell line LIM1863 (Whitehead et al. 1987). In this model system, 
LIM1863 cells growing as a two-dimensional (2D) monolayer undergo MET to form 3D highly 
organized, multicellular structures that resemble enclosed carcinoma tubules (termed 
organoids). We demonstrated cyclic transition from 2D to 3D and refer to this adapted cell line 
as LIM1863-Mph (morphogenetic) (Vincan et al. 2007a, Vincan et al. 2007b, Vincan et al. 
2008). The dynamic phenotype transitions between 2D and 3D faithfully recapitulate the 
pathology of invasive (deconstructing tubular structures) and central (constructing tubular 
structures) areas of carcinoma tissues (Vincan et al. 2007a). We recorded nuclear β-catenin in 
the monolayer cells (low or undetectable Ki-67 staining), then a transient, short, sharp increase 
in nuclear β-catenin at the initiation of MET, just as the cells lift off the tissue culture plastic 
and become Ki-67 positive. This intense nuclear β-catenin rapidly subsides to undetectable 
levels as the organoids form, while Ki-67 staining is retained as all the organoid cells 
proliferate. Using RNAi-mediated knock-down in LIM1863-Mph, we demonstrated that the 
Wnt receptor Frizzled7 (FZD7) is necessary for MET (Vincan et al. 2007b). FZD7-mediated 
Wnt/β-catenin signaling is known to orchestrate tissue “constructing” morphogenetic events 
during embryonic development (e.g. epithelial organization of somites (Linker et al. 2005)) 
and our findings indicate a similar role for FZD7 in the context of CRC (Vincan et al. 2007c).  
 
However, the Wnt ligands that co-operate with FZD7 during the initiation of MET are not 
known. Here we show that Wnt is required for MET in the LIM1863-Mph model as inhibiting 
Wnt secretion blocks MET. Secretion of Wnt is dependent on porcupine (PORC) (van den 
Heuvel et al. 1993), an enzyme in the endoplasmic reticulum that post translationally 
palmitoylates Wnts at a highly conserved serine residue (Lum and Clevers 2012, Madan et al. 
2016). Inhibition of PORC with IWP2 (B. Chen et al. 2009, S. Chen et al. 2009) blocked MET. 
We identify the Wnts that are differentially expressed by mesenchymal and epithelial 
LIM1863-Mph cells using an array platform; and demonstrate that recombinant Wnt2B or the 
archetypical β-catenin activating Wnt, Wnt3a, can partially rescue MET when Wnt secretion 
is blocked by IWP2.  
 
Results 
 
Wnt expression and signaling in LIM1863-Mph cells 
 
The LIM1863-Mph cells undergo cyclic transitions between monolayer and free-floating 
organoid clusters. The organoids are spheres of highly polarized epithelial cells around a 
central lumen (Vincan et al. 2007a, Vincan et al. 2007b), shown diagrammatically in Fig. 1A. 
Having identified a role for FZD7 in orchestrating MET in the LIM1863-Mph model (Vincan 
et al. 2007b), and given that the expression of FZD7 does not change during these transitions 
(data not shown), the next important step was to identify which Wnt genes were differentially 
expressed by monolayer and organoid cells, and thus could potentially co-operate with FZD7 
in this process. To answer this question, we employed the Human Wnt Signaling Pathway 
Array (Qiagen). Total RNA was extracted from LIM1863-Mph monolayer and organoid cells, 
cDNA synthesized and assayed using the cDNA array. Relative expression was determined 
using HMBS as reference (Fig. 1B). Wnt2B, Wnt3 and Wnt10A were markedly up-regulated 
in the organoids compared to the monolayer cells; expression of Wnt4 and Wnt11 were 
relatively unchanged, while the other Wnt genes were expressed at very low levels. Looking at 
expression levels of Wnt/β-catenin target genes (Fig. 1C), these were similar in both cell types 
with less than two-fold changes in expression. The differences in Wnt2B, Wnt3 (and Wnt3A 
albeit expressed at very low levels) and Wnt target gene expression identified by the array 
analyses were validated by independent qRT-PCR on a separate set of cell preparations (Fig. 
2A & 2B). Wnt2B was the most abundant differentially expressed Wnt and was thus 
investigated further. Wnt2B expression in the LIM1863-Mph organoids was confirmed by 
immunofluorescence and confocal microscopy, in which we observed Wnt2B localized in 
puncta apical to the nuclei of LIM1863-Mph organoid cells (Fig. 2C). As shown previously 
(Vincan et al. 2007a, Vincan et al. 2007b), laminin–γ2, a marker for the invasive front (Hlubek 
et al. 2001) is very strongly up-regulated (~30 fold) in the mesenchymal cells compared to the 
mature organoids. Similarly, the EMT marker Claudin1 (Suh et al. 2013) is also up-regulated 
in the mesenchymal cells (Fig. 2B).  
 
Wnt is necessary for MET 
 
Wnt2B functions to promote the activityof intestinal stem cells (Farin et al. 2012), 
which are also the cell-of-origin in colorectal cancer (Barker et al. 2009). Furthermore, we have 
also recently shown that Wnt2B co-operates and co-immunoprecipitates with Fzd7 in intestinal 
stem cells (Flanagan et al. 2015), and therefore we focused on the function of this Wnt in MET, 
asstem cell properties are often hijacked by cancer cells (Barker et al. 2009, Phesse et al. 2014).  
 
First, we investigated whether Wnt is necessary for MET. Wnts are secreted growth 
factors and require post-translational modification by PORC to be secreted (B. Chen et al. 2009, 
S. Chen et al. 2009, Lum and Clevers 2012, Madan et al. 2016, van den Heuvel et al. 1993). 
Inhibition of PORC enzyme activity has been shown to inhibit the secretion of  Wnts, and 
therefore we used the PORC inhibitor IWP2 as a tool to inhibit Wnt secretion. We confirmed 
inhibition of Wnt secretion using Wnt3A-L-cells, a mouse fibroblast continuous cell line that 
was stably transfected with a Wnt3A and secretes Wnt3A into the supernatant (Willert et al. 
2003). We collected conditioned medium from parental L-cells, and Wnt3A-L-cells with or 
without the PORC inhibitor IWP2 (5 µM). These conditioned media were then added to 
parental L-cells. We showed by immunoblot that Wnt3a conditioned medium induced the 
accumulation of β-catenin and that this activity was lost when the PORC inhibitor IWP2 was 
added during preparation of the Wnt3A-conditioned medium, thus confirming that that IWP2 
is functioning to inhibit Wnt secretion in these cells (Fig. 3A).  
 
Next, monolayer organoids were treated with 5 µM IWP2 as they were just starting to 
re-organize to form organoids i.e. undergoing MET. Inhibition of PORC blocked MET and the 
monolayer patch had a “cotton wool” appearance with no budding organoids, consistent with 
a mesenchymal phenotype (Vincan et al. 2007b). In contrast, numerous generating organoids 
were observed in the carrier-treated monolayer patch (Fig. 3B). Expression of the mesenchymal 
markers, laminin–γ2 and Claudin1 remained high in the IWP2 treated cells and was increased 
approximately two fold when compared to the control DMSO treated cells, confirming their 
mesenchymal phenotype (Fig. 3C). The expression of Wnt target genes was relatively 
comparable between the IWP2 treated and control cells (Fig. 3C). This is consistent with our 
observation that these genes are relatively unchanged when mesenchymal and epithelial 
LIM1863-Mph cells are compared (Fig. 1C). 
 
Wnt2B and Wn3A function in MET 
 
Following the demonstration that inhibiting Wnt secretion blocked MET, we next 
investigated if addition of recombinant Wnts could rescue/restore MET. To better visualize the 
changes in the morphology during the MET process, the cells were seeded into chamber slides 
and stained for either E-cadherin or ZO-1, to demonstrate the cell architecture. Cultures were 
treated with DMSO, 5 µM IWP2 or with 5 µM IWP2 with either Wnt2B (100 ng/ml) or the 
archetypical β-catenin-activating Wnt, Wnt3a (100 ng/ml) (Willert et al. 2003). The E-cadherin 
stained DMSO treated cultures show that organoids were re-assembling because the monolayer 
cell patches have “holes”, i.e. areas where the cells are lifting off (arrows) and starting to re-
organize themselves into organoids (indicated by the circles in Fig. 4A). In contrast, the IWP2 
treated cells remain a tight patch and the E-cadherin staining does not distinguish any organoid 
formation or cells lifting off the tissue culture plastic (Fig. 4B). Adding recombinant Wnt2B 
(Fig. 4C) or Wnt3A (Fig. 4D) restores organoid assembly with “holes” observed in the 
monolayer patches, indicating the cells are lifting off and re-organizing into organoids. The 
ZO-1 staining shows the central lumen of the organoids being assembled in the DMSO treated 
cultures (Fig. 5A indicates one example of assembling organoids). These clusters of apical ZO-
1 staining are not observed in the cultures treated with IWP2 (Fig. 5B). In contrast, the cluster 
of apical ZO-1 was clearly evident when recombinant Wnt was added to the IWP2-treated 
cultures (Fig. 5C & 5D). We have previously demonstrated that FZD7 is required for MET 
(Vincan et al. 2007b) and binds to Wnt2B (Flanagan et al. 2015). Thus, our collective data 
indicates that FZD7 transmits signals from Wnt2B to orchestrate MET in this model of 
colorectal cancer morphogenesis (Fig. 6). 
 
Discussion 
 
In CRC, aberrant activation of the Wnt/β-catenin signaling pathway leads to the 
accumulation of β-catenin in the nucleus and thus the hyper-activation of β-catenin-TCF/LEF 
gene transcription. Indeed, the over-activation of the Wnt signaling pathway, caused by 
mutations to some of its intracellular components, is found in nearly all CRCs, both sporadic 
and familial (Kinzler et al. 1991). Most notable is the tumor suppressor gene APC, which is 
found to be mutated in approximately 80-90% of CRCs. However, in addition to these APC 
mutations, the over-expression of certain upstream signaling components can regulate Wnt 
signaling activity, irrespective of the downstream pathway-activating mutations (Caldwell et 
al. 2004, Suzuki et al. 2004, Ueno et al. 2009, Vincan et al. 2007b, Vincan et al. 2005). 
Importantly, additional Wnt signaling underlies malignant progression as the acquisition of 
invasive capabilities and metastasis relies on dynamic reversible processes, EMT and MET 
(Thiery 2002). Thus, it is of great importance to understand how these processes are 
coordinated and regulated, as it may provide novel avenues to block metastasis, which is 
ultimately the cause of cancer death. The results presented in this study demonstrate the 
potential of blocking the interaction between Wnt and FZD7, as a therapeutic target to prevent 
MET and cancer recurrence (Vincan and Barker 2008). 
 
Although additional signaling by the Wnt-FZD receptor complex was initially 
considered unnecessary in CRC, it is now accepted that the upstream components participate 
in the initiation and progression of CRC.  This is based on several lines of evidence. Expression 
of nuclear β-catenin in early adenoma is not as strong as it is in later stages (Phelps et al. 2009a, 
Phelps et al. 2009b). Also, naturally occurring inhibitors of Wnt-FZD interaction, the secreted 
Frizzled related proteins (sFRPs), are bona fide tumor suppressors in CRC (Caldwell et al. 
2004, Suzuki et al. 2004), suggesting that the additional modulation of the β-catenin-dependent 
Wnt signaling pathway is via the upstream components of the pathway. Furthermore, 
epigenetic silencing of sFRP can occur before truncating mutations in APC (Suzuki et al. 2004), 
indicating that aberrant signaling from the Wnt-FZD complex may precede aberrant signaling 
due to truncation of APC. Furthermore, both Wnts (Dimitriadis et al. 2001, Katoh et al. 1996, 
Kirikoshi et al. 2001, Ru et al. 2008) and FZDs (He et al. 2011, Holcombe et al. 2002, Sagara 
et al. 1998, Ueno et al. 2008, Vincan 2004, Vincan et al. 2007b) are over-expressed in CRC 
tissues and cell lines and can additionally modulate the β-catenin-dependent Wnt signaling 
pathway (Ueno et al. 2009, Vincan et al. 2007b, Vincan et al. 2005), despite mutation to APC 
or CTNN1 (the gene that codes for β-catenin). Notably, Wnt signaling appears to be constrained 
in CRC cells [reviewed in (Phesse et al. 2016)], giving way to bursts of localized increased 
signaling as occurs at the invasive front (Brabletz et al. 2005b) where aberrant activation of the 
Wnt pathway can induce EMT in tumor cells (Kim et al. 2002, Mariadason et al. 2001, Muller 
et al. 2002). Our collective data in the LIM1863-Mph model indicates that the initiation of 
MET is associated with a brief burst of even higher Wnt/β-catenin signaling than that seen in 
the dormant mesenchymal cells at the invasive front (Brabletz et al. 2001, Vincan et al. 2007b).  
 
Using the LIM1863-Mph model system, we demonstrated a requirement for FZD7 in 
MET that is necessary to assemble the organoids (Vincan et al. 2007b), but the question of 
which Wnt ligand was signaling via FZD7 remained unanswered. There are 19 mammalian 
Wnts and here we investigated which of these Wnt ligands interacts with FZD7 to activate 
MET. First, we employed a gene array and identified Wnt2B, Wnt3 and Wnt10A as 
differentially expressed by mesenchymal and organoid LIM1863-Mph cells. Next, we 
demonstrated a requirement for Wnt in the assembly of organoids by demonstrating that 
inhibition of Wnt secretion using IWP2 blocked MET. We chose to further investigate the role 
of Wnt2B in the LIM1863-Mph cells as we had identified this Wnt as a signaling partner of 
FZD7 in intestinal stem cells (Flanagan et al. 2015) and Wnt2B can activate β-catenin-
dependent Wnt signaling (Goss et al. 2009). Furthermore, although it has been suggested that 
RNAi-mediated inhibition of PORCUPINE can suppress the growth of breast cancer cells in a 
Wnt independent mechanism, this did not phenocopy treatment with IWP-2 (cells did not 
respond to IWP-1 or IWP-2) (REF TO ADD; Covey et al, PLoS One, 2012, PLoS ONE 7(4): 
e34532.). . Indeed, we demonstrate that recombinant Wnt2B (or the archetypical β-catenin-
activating Wnt, Wnt3A (Willert et al. 2003)) could restore MET when Wnt secretion was 
inhibited in the monolayer LIM1863-Mph cells. Notably, Wnt2B mediated β-catenin-
dependent Wnt signaling is implicated during the morphogenesis of renal tubes (Iglesias et al. 
2007), which is one of the key MET events during development. Thus a role for Wnt2B in 
promoting the formation of glandular structures in CRC is consistent with its role during 
development. Furthermore, Wnt2B was also one of the first Wnts demonstrated to be over-
expressed in CRC cell lines (Bafico et al. 2004, Katoh et al. 1996); Notably, Wnt3 is also 
overexpressed in colorectal tumors (Voloshanenko et al. 2013). Thus the role we identify for 
Wnt2B, and potentially Wnt3, are consistent with over-expression reported for these Wnts in 
colorectal cancer. 
 
Wnt3 produced by Paneth cells in the epithelium is essential for intestinal stem cells 
(Sato et al. 2011, Sato et al. 2009). In the absence of Wnt3, Wnt2B can compensate (Farin et 
al. 2012). More recently, it was shown, that high levels of Wnt2B are predominantly expressed 
in Gli1 positive sub-epithelial mesenchymal cells, which are adjacent to the crypts (Valenta et 
al. 2016). This localization of Wnt2B is consistent with previous reports showing Wnt2b 
expression in the mesenchyme of mouse intestine (Gregorieff et al. 2005). Collectively, these 
studies identify Wnt2B and Wnt3 as intestinal stem cell Wnts. Intriguingly, the data presented 
here indicates that these stem cell Wnts also function in colorectal cancer morphogenesis 
indicating that the stem cell Wnts, like FZD7, feature in colorectal cancer. Notably, we 
demonstrated that FZD7 stem cell function can be partially compensated by closely related 
FZD genes, FZD1 and FZD2 (Flanagan et al. 2015), however, the same compensatory 
mechanism does not appear to occur in cancer as knock-down of FZD7 blocks MET (Vincan 
et al. 2007b), and inhibiting FZD7 function with a dominant-negative receptor ectodomain has 
potent antitumor activity in colorectal cancer (Vincan et al. 2005) and other cancers such as 
liver cancer [reviewed in (Vincan and Barker 2008)].  
 
Colorectal cancer (CRC) is a major health problem worldwide that is exacerbated by 
an aging population. CRC can effectively be cured if it remains localized and is surgically 
resected, however cancer cells often spread to other organs with metastases underlying most 
CRC mortality. Clearly better strategies are needed to stop tumor recurrence, which will 
ultimately lead to better management and treatment of advanced CRC, and consequently, 
increase patient survival. Furthermore, reversible EMT and MET underpins metastasis of other 
solid tumors (Ocana et al. 2012), thus the mechanisms for MET reported here might also be 
relevant to other forms of cancer. 
 
Experimental Procedures 
 
Cell lines, cell culture and live cell imaging 
Cells lines were either purchased from ATCC (HEK293), provided by the Ludwig 
Institute for Cancer Research (LIM1863) (Whitehead et al. 1987) or the Nusse laboratory 
(parental L-cells and Wnt3a-Lcells) (Willert et al. 2003). The adapted LIM1863-Mph line has 
been previously described (Vincan et al. 2007a, Vincan et al. 2008). Cells were cultured in 
RPMI 1640 medium (GIBCO, 11875-119), supplemented with 10% heat inactivated fetal calf 
serum (FSC, Chemicon International, Embryo Max FCS, ES qualified ES-009-A), 20 mM 
HEPES, Glutamine and antibiotics (Penicillin/Streptomycin). The LIM1863-Mph cells were 
cultured in rich medium with additional supplements [1 µg/mL hydrocortisone (Solu-Cortef 
for injection), ~0.9-1µg/mL insulin (Insulin for injection, 100U/mL, from Pharmacy) and 10-
4M 1-thioglycerol (Sigma, M6145)]. The cells were incubated at 37˚C in a humidified 
atmosphere containing 10% CO2.  
To plate the LIM1863-Mph so that they preferentially form monolayer patches, 
adherent LIM1863-Mph cells were detached with Trypsin/EDTA solution [0.05% (w/v trypsin 
1:250, 0.02% (w/v) EDTA, pH7.0] and seeded at 5 x 103 cells/cm2 tissue culture well surface 
area as previously described (Vincan et al. 2008).  
Differential interference contrast (DIC) images of LIM1863-Mph cultures were taken 
on a Nikon Ti-E microscope using either a 4× Plan Fluor NA 0.13 objective or a 10× Plan Fluor 
NA 0.3 objective. A focal stack of images was collected 10µm apart and processed through the 
“Best Focus” function of MetaMorph v7.7.7 (Molecular Devices) to generate the final image 
(Vincan et al. 2007b). 
 
Detection of β-catenin by immunoblot 
L-cells were seeded in replicate wells treated with conditioned medium (CM) harvested 
from the L-cell parental line, or the Wnt3a-producing cell line (Willert et al. 2003) with or 
without the Porcupine inhibitor IWP2 (B. Chen et al. 2009, S. Chen et al. 2009). After treatment 
with the conditioned media, the L-cells were washed with warm calcium and magnesium free 
phosphate buffered saline (PBS=) and then scraped from the well in to ~1 ml of PBS=. The cells 
were then pelleted at 1200 rpm for 2min and resuspended in 50 µl of PBS=, followed 
immediately by the addition of hot (≥95°C) 2x Laemmli Sample Buffer (Bio-Rad Laboratories, 
161-0737) with 0.5M β-mercaptoethanol and then incubated at ≥95°C for 5 min. The whole 
cell lysate protein samples were separated by SDS-PAGE (sodium dodecyl sulfate 
polyacrylamide gel electrophoresis) and the separated proteins transferred to a nitrocellulose 
membrane (Hybond C-Extra, Amersham, RPN303E). After transfer, the membrane was 
blocked with 5% (w/v) skim milk powder in Tris buffered saline (TBS) with 0.1% Tween-20 
(TBS-T) for 1hr at room temperature, rinsed and incubated overnight in primary antibody 
(mouse anti-β-catenin, BD Transduction Labs, 610154) at 4˚C. Following the overnight 
incubation, the primary antibody was washed off with TBS-T and the bound antibody detected 
with anti-mouse-HRP (DAKO, P0161) and Enhanced Chemiluminescence (ECL) [Clarity 
Western ECL Substrates; Luminol/enhancer reagent and Peroxide reagent (Bio-Rad, 
1705060)].  
 
Immunofluorescence staining 
To stain LIM1863-Mph during MET, detached monolayer cells were seeded at 5 x 
103/cm2 in 2-chamber slides (Lab-Tek, 177429) as described (Vincan et al. 2008) and given 
the indicated treatments. Following treatment, the growth medium was removed and the cells 
were washed twice in PBS++ (PBS with Mg++/Ca++) and fixed in situ with methanol at -20°C 
for 20 min. The cells were incubated for 1hr in 5% FCS in 0.2% PBST to block nonspecific 
binding of the antibodies. The primary antibody was diluted in 5% FCS in 0.05% PBST (PBS 
+ 0.05% Triton X-100), and left overnight at 4˚C. After washing, the cells were incubated in 
the secondary antibody for 1hr at room temperature and then DAPI (4'-6-Diamidino-2-
phenylindole) was added to stain the nuclei. The cells were mounted in 70% glycerol for 
confocal microscopy. The primary antibodies used were mouse anti-E-cadherin (BD 
Transduction Labs, 610181) and mouse anti-ZO-1 (Invitrogen, 339100). Secondary antibody 
was Alexa anti-mouse 568. Detection of the staining for the chamber slides was captured on a 
Leica LAS AF SP5 microscope using a 20× HCX Plan Apo NA 0.7 IMM objective.  
Free-floating organoids were fixed in 4.0% paraformaldehyde in PBS= and 
permeabilized with 0.2% PBST (PBS= with 0.2% Triton X-100). Primary antibody was E-
cadherin and rabbit anti-Wnt2B (abcam, ab50575). Secondary antibodies were Alexa anti-
mouse 594 and Alexa anti- rabbit 488. Staining of the free-floating organoids was captured 
using the Zeiss LSM Meta confocal. 
Z-stacks of images was collected and processed in ImageJ v1.43u, then finalized in 
Adobe Photoshop CS4 v11.0.2 to generate the final image. All images from an experiment 
were processed in the same way. 
 
RNA extraction, cDNA synthesis and quantitative PCR 
Gene expression by qRT-PCR (quantitative reverse transcriptase polymerase chain 
reaction) was performed as we previously described (Vincan et al. 2005). Briefly, following 
treatment, the cells were harvested in TRIzol (Invitrogen 15596-018) and total RNA was 
purified and DNAse treated using RNeasy mini-prep columns (Qiagen 74104). cDNA was 
synthesized from 4µg of total RNA using anchored oligodT primers (Promega) and Moloney 
Murine Leukemia Virus Reverse Transcriptase (M-MLV RT, Promega M1705). Quantitative 
PCR on the cDNA samples was performed using SYBR green (Invitrogen 4309155) and ABI 
PRISM 7500 Sequence Detector (Applied Biosystems). The housekeeping gene 
hydroxymethyl-bilane synthase (HMBS) (Vandesompele et al. 2002) was used to calculate the 
fold change (2ΔΔCT method) as described (Vincan et al. 2005). Primer sequences are available 
on request. 
For the array analysis, cDNA (four separate monolayer and organoid populations) was 
synthesized as above and then assayed on the Human Wnt Signaling Pathway Array (Qiagen, 
PAHS-043YA). HMBS expression was determined by qPCR as above and used to calculate 
the fold change (2ΔΔCT method) as described (Vincan et al. 2005). 
 
Statistical analysis 
Data are expressed as mean ± SEM, where mean represents number of experiments (three or 
more). Statistical tests used are Student’s t test or Mann-Whitney with Prism6 (GraphPad 
software) where P values of ≤ 0.05 were considered significant. 
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